- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 209/12 - Radicals substituted by oxygen atoms
Patent holdings for IPC class C07D 209/12
Total number of patents in this class: 606
10-year publication summary
|
49
|
40
|
44
|
51
|
24
|
35
|
22
|
44
|
31
|
18
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Achillion Pharmaceuticals, Inc. | 164 |
14 |
| FUJIFILM Corporation | 29696 |
13 |
| Bristol-myers Squibb Company | 4849 |
12 |
| Janssen Pharmaceuticals, Inc. | 437 |
12 |
| Sensorium Therapeutics, Inc. | 34 |
12 |
| Vertex Pharmaceuticals Incorporated | 1626 |
10 |
| BioCryst Pharmaceuticals, Inc. | 175 |
10 |
| The Johns Hopkins University | 5714 |
9 |
| Katholieke Universiteit Leuven | 1197 |
9 |
| California Institute of Technology | 3984 |
8 |
| Novartis AG | 10721 |
7 |
| Kanna Health Ltd. | 12 |
7 |
| Versicolor Technologies, LLC | 10 |
6 |
| The Regents of the University of California | 20108 |
5 |
| Wyeth LLC | 655 |
5 |
| The Board of Trustees of the University of Illinois | 2719 |
5 |
| Toyama Chemical Co., Ltd. | 101 |
5 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2874 |
5 |
| F. Hoffmann-La Roche AG | 7948 |
4 |
| BASF SE | 21017 |
4 |
| Other owners | 444 |